Pharmaceuticals sentiment remains resilient in the latest Q3 FY26 read, according to publicly available indicators and market commentary tracked by the desk.
Key points tracked: sentiment remains resilient; participants pointed to improving liquidity; the broader trend stayed in line with recent sessions.
Why it matters: shifts in pharmaceuticals sentiment are a useful gauge of the underlying momentum in the sector and can shape near-term positioning.